These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 24895216)
1. Optimization and validation of a high throughput method for detecting neutralizing antibodies against human papillomavirus (HPV) based on pseudovirons. Nie J; Huang W; Wu X; Wang Y J Med Virol; 2014 Sep; 86(9):1542-55. PubMed ID: 24895216 [TBL] [Abstract][Full Text] [Related]
2. A comparative study of two different assay kits for the detection of secreted alkaline phosphatase in HPV antibody neutralization assays. Kemp TJ; Matsui K; Shelton G; Safaeian M; Pinto LA Hum Vaccin Immunother; 2015; 11(2):337-46. PubMed ID: 25695397 [TBL] [Abstract][Full Text] [Related]
3. Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18. Pastrana DV; Buck CB; Pang YY; Thompson CD; Castle PE; FitzGerald PC; Krüger Kjaer S; Lowy DR; Schiller JT Virology; 2004 Apr; 321(2):205-16. PubMed ID: 15051381 [TBL] [Abstract][Full Text] [Related]
4. Development of a Triple-Color Pseudovirion-Based Assay to Detect Neutralizing Antibodies against Human Papillomavirus. Nie J; Liu Y; Huang W; Wang Y Viruses; 2016 Apr; 8(4):107. PubMed ID: 27120611 [TBL] [Abstract][Full Text] [Related]
5. Evolution of type-specific immunoassays to evaluate the functional immune response to Gardasil: a vaccine for human papillomavirus types 16, 18, 6 and 11. Smith JF; Kowalski R; Esser MT; Brown MJ; Bryan JT Hum Vaccin; 2008; 4(2):134-42. PubMed ID: 18388490 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the immunogenicity and reactogenicity of Cervarix and Gardasil human papillomavirus vaccines in HIV-infected adults: a randomized, double-blind clinical trial. Toft L; Storgaard M; Müller M; Sehr P; Bonde J; Tolstrup M; Østergaard L; Søgaard OS J Infect Dis; 2014 Apr; 209(8):1165-73. PubMed ID: 24273179 [TBL] [Abstract][Full Text] [Related]
7. Potent anti-HPV immune responses induced by tandem repeats of the HPV16 L2 (20 -- 38) peptide displayed on bacterial thioredoxin. Rubio I; Bolchi A; Moretto N; Canali E; Gissmann L; Tommasino M; Müller M; Ottonello S Vaccine; 2009 Mar; 27(13):1949-56. PubMed ID: 19368776 [TBL] [Abstract][Full Text] [Related]
8. Neutralization of human papillomavirus type 11 (HPV-11) by serum from women vaccinated with yeast-derived HPV-11 L1 virus-like particles: correlation with competitive radioimmunoassay titer. Brown DR; Bryan JT; Schroeder JM; Robinson TS; Fife KH; Wheeler CM; Barr E; Smith PR; Chiacchierini L; DiCello A; Jansen KU J Infect Dis; 2001 Nov; 184(9):1183-6. PubMed ID: 11598842 [TBL] [Abstract][Full Text] [Related]
9. [Establishment and evaluation of a triple-color human papillomavirus pseudovirion neutralization assay]. Wei SP; Fan F; Chen J; Liu XL; Yang YR; Wang ZP; Song S; Li ZH; Wei MX; Wang DN; Li SW; Xia NS Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Oct; 52(10):1039-1044. PubMed ID: 30392324 [No Abstract] [Full Text] [Related]
10. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region. Kondo K; Ishii Y; Ochi H; Matsumoto T; Yoshikawa H; Kanda T Virology; 2007 Feb; 358(2):266-72. PubMed ID: 17010405 [TBL] [Abstract][Full Text] [Related]
11. Characterization of serum antibodies from women immunized with Gardasil: A study of HPV-18 infection of primary human keratinocytes. Wang HK; Wei Q; Moldoveanu Z; Huh WK; Vu HL; Broker TR; Mestecky J; Chow LT Vaccine; 2016 Jun; 34(27):3171-3177. PubMed ID: 27113165 [TBL] [Abstract][Full Text] [Related]
12. Development and validation of a cell-based SEAP reporter assay for the detection of neutralizing antibodies against an anti-IL-13 therapeutic antibody. Liao K; Sikkema D; Wang C; Chen K; DeWall S; Lee TN J Immunol Methods; 2012 Jan; 375(1-2):258-63. PubMed ID: 22001556 [TBL] [Abstract][Full Text] [Related]
13. [Establishment and application of human papillomavirus type 16 pseudovirions neutralization assay]. Lu WX; Cheng T; Li SW; Pan HR; Shen WT; Chen YX; Zhang T; Zheng Z; Zhang J; Xia NS Sheng Wu Gong Cheng Xue Bao; 2006 Nov; 22(6):990-5. PubMed ID: 17168325 [TBL] [Abstract][Full Text] [Related]
14. Neutralizing and cross-neutralizing antibody titres induced by bivalent and quadrivalent human papillomavirus vaccines in the target population of organized vaccination programmes. Barzon L; Squarzon L; Masiero S; Pacenti M; Marcati G; Mantelli B; Gabrielli L; Pascucci MG; Lazzarotto T; Caputo A; Palù G Vaccine; 2014 Sep; 32(41):5357-62. PubMed ID: 25045814 [TBL] [Abstract][Full Text] [Related]
15. Preclinical model to test human papillomavirus virus (HPV) capsid vaccines in vivo using infectious HPV/cottontail rabbit papillomavirus chimeric papillomavirus particles. Mejia AF; Culp TD; Cladel NM; Balogh KK; Budgeon LR; Buck CB; Christensen ND J Virol; 2006 Dec; 80(24):12393-7. PubMed ID: 17005666 [TBL] [Abstract][Full Text] [Related]
16. Concordance assessment between a multiplexed competitive Luminex immunoassay, a multiplexed IgG Luminex immunoassay, and a pseudovirion-based neutralization assay for detection of human papillomaviruse types 16 and 18. Brown D; Müller M; Sehr P; Pawlita M; Seitz H; Rubio I; Antonello J; Radley D; Roberts C; Saah A Vaccine; 2014 Oct; 32(44):5880-7. PubMed ID: 25148777 [TBL] [Abstract][Full Text] [Related]
17. Neutralization of human papillomavirus (HPV) pseudovirions: a novel and efficient approach to detect and characterize HPV neutralizing antibodies. Yeager MD; Aste-Amezaga M; Brown DR; Martin MM; Shah MJ; Cook JC; Christensen ND; Ackerson C; Lowe RS; Smith JF; Keller P; Jansen KU Virology; 2000 Dec; 278(2):570-7. PubMed ID: 11118379 [TBL] [Abstract][Full Text] [Related]
18. Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus species. Gambhira R; Gravitt PE; Bossis I; Stern PL; Viscidi RP; Roden RB Cancer Res; 2006 Dec; 66(23):11120-4. PubMed ID: 17145854 [TBL] [Abstract][Full Text] [Related]
19. Induction of neutralizing antibodies to papillomaviruses by anti-idiotypic antibodies. Christensen ND; Reed CA; Cladel NM Virology; 1995 Jul; 210(2):292-301. PubMed ID: 7542415 [TBL] [Abstract][Full Text] [Related]
20. Humoral and cellular immune responses to airway immunization of mice with human papillomavirus type 16 virus-like particles and mucosal adjuvants. Revaz V; Zurbriggen R; Moser C; Schiller JT; Ponci F; Bobst M; Nardelli-Haefliger D Antiviral Res; 2007 Oct; 76(1):75-85. PubMed ID: 17617476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]